From October 1, 2023 to February 8, 2024, the company has repurchased 194,554 shares, representing 0.12% for CNY 20.06 million. With this, the company has completed the repurchase of 496,600 shares, representing 0.32% for CNY 49.98 million under the buyback announced on August 11, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
118.8 CNY | -1.82% | -6.05% | -5.66% |
04-22 | Anhui Huaheng Biotechnology's Q1 Profit Jumps 7% | MT |
04-22 | Anhui Huaheng Biotechnology's 2023 Profit Jumps 40% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.66% | 2.63B | |
+1.82% | 29.86B | |
+19.20% | 24.81B | |
+7.19% | 11.19B | |
+17.15% | 5.44B | |
+20.00% | 4.54B | |
-7.50% | 3.79B | |
+3.26% | 3.36B | |
+1.25% | 3.12B | |
+29.04% | 2.86B |
- Stock Market
- Equities
- 688639 Stock
- News Anhui Huaheng Biotechnology Co., Ltd.
- Tranche Update on Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback Plan announced on August 11, 2023.